Are you looking to stay current with all of the latest Pulmonology news articles and research? Look no further! MDLinx Pulmonology medical editors extensively research respiratory medical journals to find the most beneficial Pulmonology clinical literature. Topics range from: Pediatric Pulmonology, Sleep Disorders, Asthma, COPD, Cystic Fibrosis and much more. In a matter of minutes, Pulmonologists and their staff can stay up to date with the most current published information.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We also feature clinical pearls from our Internal Medicine Physician Review. You can also get the latest updates on salary information, search available Pulmonology jobs, view upcoming Pulmonology and CME conferences and earn some extra cash by participating in Market Research opportunities.
Not yet an MDLinx.com Member??? Sign up now to gain access to MDLinx exclusive content, email alerts that keep you current on the latest medical news, research, and clinical articles on the topics of your choice, special communications and offers from MDLinx and our sponsors. Plus, you can now post your CV to the MDLinx Career Center to be viewed top medical recruiters who will help you find your next dream job.
Your Unread Messages in Pulmonology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pediatric Pulmonology Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Risk factors for MRSA
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
221 Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes Acta Oncologica, May 21, 2013 Clinical Article
222 Early mortality after surgical resection for lung cancer: an analysis of the english national lung cancer audit Thorax, May 21, 2013 Clinical Article
223 High-grade Lung Adenocarcinoma With Fetal Lung-like Morphology: Clinicopathologic, Immunohistochemical, and Molecular Analyses of 17 Cases American Journal of Surgical Pathology , May 21, 2013 Clinical Article
224 Assessing the component associations of the healthy worker survivor bias: occupational asbestos exposure and lung cancer mortality Annals of Epidemiology , May 21, 2013 Review Article
225 Photodynamic therapy for bronchial carcinoid tumours: complete response over a 10-year follow-up European Journal of Cardio-Thoracic Surgery, May 21, 2013
226 Pulmonary adenofibroma in a middle-aged man: report of a case Surgery Today, May 21, 2013
227 Tumor Heterogeneity as measured on the CT component of PET/CT Predicts Survival in Patients with Potentially Curable Non-Small Cell Lung Cancer Clinical Cancer Research, May 20, 2013 Clinical Article
228 Long-Term Outcome of Proton Therapy and Carbon-Ion Therapy for Large (T2a-T2bN0M0) Non-Small-Cell Lung Cancer Journal of Thoracic Oncology, May 20, 2013 Clinical Article
229 Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma Full Text BMC Cancer, May 20, 2013 Clinical Article
230 Translation Initiation Factor eIF3b Expression in Human Cancer and Its Role in Tumor Growth and Lung Colonization Clinical Cancer Research, May 20, 2013 Review Article
231 Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma? Lung Cancer, May 20, 2013
232 The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib Journal of Thoracic Oncology, May 20, 2013 Clinical Article
233 Interobserver Agreement in the Nuclear Grading of Primary Pulmonary Adenocarcinoma Journal of Thoracic Oncology, May 20, 2013 Clinical Article
234 Completing the Audit Cycle Improves Surgical Standards in Lung Cancer: Why Do Some Patients Still Not Receive the Best Care Journal of Thoracic Oncology, May 20, 2013 Clinical Article
235 Results of the First Italian External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small-Cell Lung Cancer Journal of Thoracic Oncology, May 20, 2013 Clinical Article
236 Results of T4 Surgical Cases in the Japanese Lung Cancer Registry Study: Should Mediastinal Fat Tissue Invasion Really be Included in the T4 Category Journal of Thoracic Oncology, May 20, 2013 Clinical Article
237 Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1) Journal of Thoracic Oncology, May 20, 2013 Clinical Article
238 Heme-related gene expression signatures of meat intakes in lung cancer tissues Molecular Carcinogenesis, May 20, 2013 Clinical Article
239 Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell Tumor Biology, May 20, 2013 Clinical Article
240 The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression Medical Oncology, May 20, 2013 Clinical Article
Using a murine mouse model of pneumonia, prolonged simvastatin therapy has a measureable effect on Streptococcus pneumoniae infection, but no effect on mortality. Mice were treated with simvastatin (1 mg/kg/d [low dose] or 10 mg/kg/d [high dose]) for 4 weeks, then infected with S. pneumoniae intrathecally. Mice treated with the high-dose regimen had less lung consolidation, decreased macrophage and neutrophil infiltration, decreased MCP-1, KC, and ICAM-1 production, and decreased bacterial titers in the blood 36 and 42 h post-infection. Despite these favorable physiologic effects, there was no effect on mortality compared to control mice treated with ampicillin 48 h post-infection.
Read the article summaryAs published in the European Journal of Internal Medicine, there were no mortalities in patients with community-acquired pneumonia (CAP) and low levels of D-dimer (< 500 ug/l). Of 147 patients in the study, D-dimer levels were elevated in those with severe CAP (2166 vs. 1630 ug/l), day 30-clinical failure (2228 vs. 1594 ug/l), early failure (2499 vs. 1669 ug/l), and non-survivors (3025 vs. 1680 ug/l). Importantly, D-dimer levels were not shown to be associated with clinical outcome based on multivariate analysis.
Read the article summaryAs published in the Journal of Infection, 114 of 981 (11.6%) of patients with pneumococcal pneumonia were bacteremic. Risk factors for bacteremia included immunosuppressants, age < 65 years, and diabetes mellitus. Patients with pneumococcal pneumonia and bacteria were at increased risk for mortality (28.6% vs. 8.5%). The combination of bacteremia, cerebrovascular disease, and septic shock had a strong association with mortality in patients with pneumococcal pneumonia.
Read the article summaryIndexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close